Search

everythinglearnresearchcommunity

for

Search:↓

Betulinic acid can help treat hepatitis C by stopping virus replication.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

BAF200 is essential for proper heart and coronary artery formation.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Upadacitinib improved multiple immune-related conditions in one patient.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.

Minoxidil with propranolol and diuretics lowers blood pressure but causes fluid retention and hair growth.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Baricitinib works better than methotrexate for severe alopecia areata.

Gefitinib can cause slower, finer, brittle, and curly scalp hair.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

JAK inhibitors may help treat alopecia areata in children, but their safety needs careful evaluation.

Beta-blockers can cause rare skin side-effects, which usually improve after stopping the medication.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Baricitinib effectively treated hair loss and inflammation in a patient with alopecia areata and lichen planopilaris.

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.

Oral JAK inhibitors show promise for treating alopecia areata but have challenges like relapse and side effects.

Access to JAK inhibitors for alopecia areata should be improved in the Military Healthcare System.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.